EvlaBio is a healthcare company, headquartered in France.
Develops monoclonal antibody for immune disorders. Seed €21M. | 2026-04-30: EUR 21M seed round Jul 10 2025 led by Kurma Partners, with…Read full notes
Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.
Already a member? Sign in